Testing Dietary and Allergen Approaches in People With Asthma
Studies dietary supplements and an allergen challenge in adults with asthma.
Plain-language title generated from the registry record
Registry title: Asthma Inflammation Research
Key facts
- Where
- Cleveland, United StatesSee the site
- Phase
- Early phase 1
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
Source: NCT01536522, who can take part
Where in United States
- Cleveland ClinicCleveland, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- The Cleveland Clinic
- Trial code
- NCT01536522
- Record updated
- 28 May 2026
- Original description
The overall goal of the Asthma Inflammation Research [AIR] Translational Program is to create an integrated multidisciplinary team for the focused purpose of development of diagnostic and prognostic tests informative for airway inflammation, and for the design of innovative, targeted biologic therapeutics.Read full original descriptionShow less
Asthma Inflammation Research
The overall goal of the Asthma Inflammation Research [AIR] Translational Program is to create an integrated multidisciplinary team for the focused purpose of development of diagnostic and prognostic tests informative for airway inflammation, and for the design of innovative, targeted biologic therapeutics.
The overarching aims of the AIR program are to conceptualize, develop, and test the next-generation therapeutics, and novel asthma diagnostic and prognostic tools that will allow us to improve the standard of asthma care.
Inclusion: Asthma diagnosed by a medical specialist and/or history of positive methacholine rest and/or reversibility of >10% of FEV1; FEV1 is within acceptable limits; Informed Consent is present.
Exclusion: Any milk allergies; Coconut allergies; Current smoking or smoking history of greater than 10 pack-years; Any other significant respiratory or cardiac disease or the presence of clinically important comorbidities, including, uncontrolled coronary artery disease, acute or and chronic renal failure; Diabetes (fasting blood sugar >110 mg/dL); BMI >40 kg/m2,; Inability to maintain diet intervention.